Life Science Company
Bristol-Myers Squibb has acquired 20 companies, including 6 in the last 5 years. A total of 2 acquisitions came from private equity firms. It has also divested 12 assets.
Bristol-Myers Squibb’s largest acquisition to date was in 2019, when it acquired Celgene for $74.0B. It’s largest disclosed sale occurred in 2001, when it sold Clairol to The Procter & Gamble for $5.0B. Bristol-Myers Squibb has acquired in 8 different US states, and 4 countries. The Company’s most targeted sectors include life science (100%).
Join Mergr and gain access to Bristol-Myers Squibb’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Summary
-
M&A Total Activity31
- M&A Buy Activity19
- M&A Sell Activity12
- Total Sectors Invested 1
- Total Countries Invested 4
- M&A Buy/Sell Connections 14
- M&A Advisors 10
Unlimited Searches
